Cargando…

No Signs of Neuroinflammation in Women With Chronic Fatigue Syndrome or Q Fever Fatigue Syndrome Using the TSPO Ligand [(11)C]-PK11195

BACKGROUND AND OBJECTIVES: The pathophysiology of chronic fatigue syndrome (CFS) and Q fever fatigue syndrome (QFS) remains elusive. Recent data suggest a role for neuroinflammation as defined by increased expression of translocator protein (TSPO). In the present study, we investigated whether there...

Descripción completa

Detalles Bibliográficos
Autores principales:	Raijmakers, Ruud, Roerink, Megan, Keijmel, Stephan, Joosten, Leo, Netea, Mihai, van der Meer, Jos, Knoop, Hans, Klein, Hans, Bleeker-Rovers, Chantal, Doorduin, Janine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8611501/ https://www.ncbi.nlm.nih.gov/pubmed/34815320 http://dx.doi.org/10.1212/NXI.0000000000001113

Ejemplares similares

Multi-omics examination of Q fever fatigue syndrome identifies similarities with chronic fatigue syndrome
por: Raijmakers, Ruud P. H., et al.
Publicado: (2020)

A possible role for mitochondrial-derived peptides humanin and MOTS-c in patients with Q fever fatigue syndrome and chronic fatigue syndrome
por: Raijmakers, Ruud P. H., et al.
Publicado: (2019)

A possible link between recurrent upper respiratory tract infections and lower cytokine production in patients with Q fever fatigue syndrome
por: Raijmakers, Ruud P.H., et al.
Publicado: (2019)

Interferon-γ and CXCL10 responses related to complaints in patients with Q fever fatigue syndrome
por: Raijmakers, Ruud P. H., et al.
Publicado: (2018)

The Qure study: Q fever fatigue syndrome – response to treatment; a randomized placebo-controlled trial
por: Keijmel, Stephan P, et al.
Publicado: (2013)

Cytokine inhibition in chronic fatigue syndrome patients: study protocol for a randomized controlled trial
por: Roerink, Megan E., et al.
Publicado: (2015)

[(11)C]-DPA-713 and [(18)F]-DPA-714 as New PET Tracers for TSPO: A Comparison with [(11)C]-(R)-PK11195 in a Rat Model of Herpes Encephalitis
por: Doorduin, Janine, et al.
Publicado: (2009)

The TSPO-specific Ligand PK11195 Protects Against LPS-Induced Cognitive Dysfunction by Inhibiting Cellular Autophagy
por: Lan, Nannan, et al.
Publicado: (2021)

Cytokine signatures in chronic fatigue syndrome patients: a Case Control Study and the effect of anakinra treatment
por: Roerink, Megan E., et al.
Publicado: (2017)

Fatigue following Acute Q-Fever: A Systematic Literature Review
por: Morroy, Gabriella, et al.
Publicado: (2016)

Abnormal neuroinflammation in fibromyalgia and CRPS using [(11)C]-(R)-PK11195 PET
por: Seo, Seongho, et al.
Publicado: (2021)

Evaluation of age-related changes in translocator protein (TSPO) in human brain using (11)C-[R]-PK11195 PET
por: Kumar, Ajay, et al.
Publicado: (2012)

TSPO Ligands PK11195 and Midazolam Reduce NLRP3 Inflammasome Activation and Proinflammatory Cytokine Release in BV-2 Cells
por: Feng, Hao, et al.
Publicado: (2020)

Have (R)-[(11)C]PK11195 challengers fulfilled the promise? A scoping review of clinical TSPO PET studies
por: Chauveau, Fabien, et al.
Publicado: (2021)

Impact of Q-fever fatigue syndrome on patients’ work status
por: Reukers, D F M, et al.
Publicado: (2020)

The Effect of the Classical TSPO Ligand PK 11195 on In Vitro Cobalt Chloride Model of Hypoxia-like Condition in Lung and Brain Cell Lines
por: Amara, Rula, et al.
Publicado: (2022)

Long-Lasting Transcriptional Changes in Circulating Monocytes of Acute Q Fever Patients
por: Raijmakers, Ruud Ph, et al.
Publicado: (2019)

A fatal case of disseminated chronic Q fever: a case report and brief review of the literature
por: Keijmel, Stephan P., et al.
Publicado: (2016)

Interleukin-1 as a mediator of fatigue in disease: a narrative review
por: Roerink, Megan E., et al.
Publicado: (2017)

The TSPO Ligands 2-Cl-MGV-1, MGV-1, and PK11195 Differentially Suppress the Inflammatory Response of BV-2 Microglial Cell to LPS
por: Azrad, Maya, et al.
Publicado: (2019)

In vitro evaluation of the anti-leishmanial activity and toxicity of PK11195
por: Guedes, Carlos Eduardo Sampaio, et al.
Publicado: (2018)

Investigating neural mechanisms of change of cognitive behavioural therapy for chronic fatigue syndrome: a randomized controlled trial
por: van Der Schaaf, Marieke E, et al.
Publicado: (2015)

Clinical assessment of the physical activity pattern of chronic fatigue syndrome patients: a validation of three methods
por: Scheeres, Korine, et al.
Publicado: (2009)

Kinetic analysis and test-retest variability of the radioligand [(11)C](R)-PK11195 binding to TSPO in the human brain - a PET study in control subjects
por: Jučaite, Aurelija, et al.
Publicado: (2012)

A Modest Increase in (11)C-PK11195-Positron Emission Tomography TSPO Binding in Depression Is Not Associated With Serum C-Reactive Protein or Body Mass Index
por: Schubert, Julia J., et al.
Publicado: (2021)

[(11)C]PK11195 binding in Alzheimer disease and progressive supranuclear palsy
por: Passamonti, Luca, et al.
Publicado: (2018)

Cross-Cultural Study of Information Processing Biases in Chronic Fatigue Syndrome: Comparison of Dutch and UK Chronic Fatigue Patients
por: Hughes, Alicia M., et al.
Publicado: (2017)

The Efficacy of the Novel TSPO Ligands 2-Cl-MGV-1 and 2,4-Di-Cl-MGV-1 Compared to the Classical TSPO Ligand PK 11195 to Counteract the Release of Chemokines from LPS-Stimulated BV-2 Microglial Cells
por: Monga, Sheelu, et al.
Publicado: (2020)

Azithromycin in Chronic Fatigue Syndrome (CFS), an analysis of clinical data
por: Vermeulen, Ruud CW, et al.
Publicado: (2006)

Involvement of steroids in anti-inflammatory effects of PK11195 in a murine model of pleurisy.
por: da Silva, Marcelo Barreto Spillere, et al.
Publicado: (2004)

[(11)C]-(R)-PK11195 positron emission tomography in patients with complex regional pain syndrome: A pilot study
por: Jeon, So Yeon, et al.
Publicado: (2017)

In Vivo Cerebral Translocator Protein (TSPO) Binding and Its Relationship with Blood Adiponectin Levels in Treatment-Naïve Young Adults with Major Depression: A [(11)C]PK11195 PET Study
por: Joo, Yo-Han, et al.
Publicado: (2021)

A research agenda for post-COVID-19 fatigue
por: Verveen, Anouk, et al.
Publicado: (2022)

Reduced complexity of activity patterns in patients with Chronic Fatigue Syndrome: a case control study
por: Burton, Christopher, et al.
Publicado: (2009)

The protective effect of PK11195 on D-galactose-induced amnestic mild cognitive impairment in rats
por: Ye, Chen, et al.
Publicado: (2020)

(11)C‐PK11195 PET imaging and white matter changes in Parkinson’s disease dementia
por: Nicastro, Nicolas, et al.
Publicado: (2019)

[(11)C]PK11195-PET Brain Imaging of the Mitochondrial Translocator Protein in Mitochondrial Disease
por: van den Ameele, Jelle, et al.
Publicado: (2021)

PT637. [11C]-(R)-PK11195 positron emission tomography in patients with complex regional pain syndrome: a pilot study
por: Jeon, Soyeon
Publicado: (2016)

The role of TSPO PET in assessing neuroinflammation
por: Crawshaw, Ania A., et al.
Publicado: (2017)

Effectiveness of Internet-Based Cognitive Behavior Therapy (Fatigue in Teenagers on the Internet) for Adolescents With Chronic Fatigue Syndrome in Routine Clinical Care: Observational Study
por: Albers, Eline, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_9spuc117g4e5co1s0f2kam1rjs